Skip to content

Continuous S-Ketamine Infusion During Laparoscopic Bariatric Surgery: The Effect on Recovery Outcome Variables and Hemodynamic Stability

Continuous S-Ketamine Infusion During Laparoscopic Bariatric Surgery: The Effect on Recovery Outcome Variables and Hemodynamic Stability

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200060618
Enrollment
Unknown
Registered
2022-06-05
Start date
2022-08-01
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bariatric Surgeries

Interventions

S-Ketamine : S-Ketamine Infusion

Sponsors

Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 60 years; 2. ASA ?-III grade; 3. BMI >= 30 kg/?; 4. Patients undergoing Laparoscopic Bariatric Surgery ; 5. The patient or family member fully understood the purpose and significance of this experiment, volunteered to participate in this clinical trial, and signed informed consent

Exclusion criteria

Exclusion criteria: 1. Drug allergy and contraindications to S-ketamine; (Patients at serious risk of hypertension or elevated intracranial pressure;??Patients with poorly controlled or untreated hypertension; Glaucoma; An untreated or undertreated patient with hyperthyroidism; 2. Complicated with serious cardiovascular, kidney disease, liver disease; 3. Have taken antidepressants or received other interventions in the past 4 weeks; 4. Patients with moderate or above anemia (hemoglobin < 90 g/L); 5. Long-term use of sedatives, analgesics, long-term alcoholism; 6. Inability to understand cooperation.

Design outcomes

Primary

MeasureTime frame
QoR40;

Secondary

MeasureTime frame
Extubation time;Eye-opening time;Time during PACU;Peak pain in PACU;Hemodynamic changes;postoperative complications in PACU;Intraoperative opioid use;Intraoperative propofol dosage;Postoperative analgesic drug use;Postoperative pain;BIS;QoR40;Time to Aldrete’s score 9;

Countries

China

Contacts

Public ContactZhiping Wang

Affiliated Hospital of Xuzhou Medical University

zhpsqxt@163.com0516 85802291

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026